BRIEF-VBI Vaccines to continue Phase I Trial of its CMV Vaccine Candidate
Aug 22 (Reuters) - Vbi Vaccines Inc
* Data safety monitoring board has no objection to co continuing enrollment in phase i clinical study to evaluate preventative cytomegalovirus vaccine candidate
* Says will continue to share clinical trial safety data with Health Canada periodically throughout study Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.